Leal Therapeutics
Develops neuro-metabolic therapeutics for schizophrenia and ALS
$30MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops neuro-metabolic therapeutics for schizophrenia and ALS
Develops oral small molecule therapies for immunological and chronic diseases
Pitching Alexandria Venture Investments? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room